Physician profile
Bruce Chau
NPI 1821173444
$22,709.35
in general payments reported to CMS, 2019-2025
40 companies · $2,614 in 2025
The $2,614 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,994 · 2020: $1,117 · 2021: $2,884 · 2022: $1,586 · 2023: $5,258 · 2024: $4,255 · 2025: $2,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,847 · Travel and Lodging: $5,129 · Gift: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,847.22 |
| Travel and Lodging | $5,128.54 |
| Gift | $151.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,674.10 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Botox |
| Allergan, INC. | $4,190.35 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,385.89 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $1,190.60 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $963.68 | 2019-2023 | Promogran Prisma, Prevena Restor Bellaform, Activ.A.C. |
| Tela Bio, INC. | $924.27 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $780.11 | 2019-2022 | |
| Mentor Worldwide LLC | $763.49 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $615.73 | 2024-2025 | Daxxify |
| Bard Peripheral Vascular, INC. | $510.39 | 2019-2023 | Lutonix Drug Coated Balloon |
| Smith+Nephew, INC. | $508.42 | 2020-2025 | Renasys Touch, Grafix Pl, Stravix |
| Polarityte, INC. | $403.62 | 2019-2020 | |
| Axogen | $312.08 | 2021-2025 | Avance Nerve Graft |
| Avita Medical Americas, LLC | $280.49 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Acera Surgical, INC. | $275.82 | 2025 | Restrata Wound Matrix |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $241.68 | 2019 | |
| Depuy Synthes Sales INC. | $233.71 | 2019-2023 | Trumatch |
| Stryker Corporation | $204.18 | 2021-2023 | Hydroset, Na |
| Solventum Corporation | $193.23 | 2025 | Prevena, Activ.A.C. |
| Zimmer Biomet Holdings, INC. | $192.67 | 2020-2022 | |
| Access Pro Medical, LLC | $185.44 | 2023-2025 | Matriderm, Matriderm |
| Urgo Medical North America, LLC | $142.10 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Acacia Pharma INC | $141.39 | 2021-2022 | |
| Baxter Healthcare | $125.59 | 2021 | |
| Tepha INC | $122.97 | 2019 | |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Acell, INC. | $112.74 | 2019 | |
| Polynovo North America LLC | $112.33 | 2024 | Novosorb Btm |
| Checkpoint Surgical, INC | $110.86 | 2021 | |
| Kls-Martin L.P. | $109.83 | 2019 | |
| Aroa Biosurgery Incorporated | $101.87 | 2022 | |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Tei Biosciences INC | $78.45 | 2019 | |
| Haemonetics Corporation | $76.23 | 2023 | Teg6s Hemostasis System |
| Musculoskeletal Transplant Foundation INC. | $72.39 | 2019-2022 | |
| Avanos Medical | $64.33 | 2019 | |
| Galderma Laboratories, L.P. | $48.00 | 2019-2023 | |
| Coopersurgical, INC. | $19.76 | 2022 | |
| Covidien LP | $18.74 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.69 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Chau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.